Rezo Therapeutics
PrivateLast Round
Series A
Nov 17, 2022
Total Funding Raised
$78M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rezo Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in November 2022.
Rezo Therapeutics is a biotechnology company that pioneers the integrated mapping of disease networks to enhance precision therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rezo Therapeutics Comparables
Compare Rezo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pepper Bio | 86% | |
| Protai | 84% | |
| Terray Therapeutics | 81% |
For institutional investors. Book with your work email.
Rezo Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rezo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| SV Angel | Series A |
| Hawktail Management | Series A |
| Norwest Venture Partners | Series A |
| SR One | Series A |
| Liquid 2 Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 132% MoM.
- Aug 12, 2025
Derek Hicks appointed as the new Chief Executive Officer.
For institutional investors. Book with your work email.
Rezo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rezo Therapeutics's valuation, stock price, and market status.
Is Rezo Therapeutics a public or private company?
Rezo Therapeutics is a private company.
What is the current stock price of Rezo Therapeutics?
Rezo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Rezo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rezo Therapeutics worth (valuation)?
Valuation information for Rezo Therapeutics is not publicly available.
Can I buy Rezo Therapeutics stock?
Rezo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rezo Therapeutics's last funding round?
Rezo Therapeutics's most recent funding round was Series A on November 17, 2022.
Who are the main investors in Rezo Therapeutics?
Key investors in Rezo Therapeutics include Andreessen Horowitz, Norwest Venture Partners, SR One.
Will Rezo Therapeutics IPO soon?
No public IPO plans have been announced for Rezo Therapeutics.
How can I track Rezo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Rezo Therapeutics's shares on secondary markets.